CNSC Practice Exam 2026 – Complete Guide for Certification Preparation

Probiotics and prebiotics are not established as standard therapy in inflammatory bowel disease. The evidence isn’t strong enough to recommend routine use for all patients with Crohn’s disease or ulcerative colitis. Some specific probiotic strains may help in particular situations (like pouchitis or certain maintenance scenarios in ulcerative colitis), but these findings aren’t universal or robust enough to apply broadly. Prebiotics can be poorly tolerated and may not provide consistent benefit, so they aren’t recommended as a standard treatment. In short, there aren’t evidence-based guidelines endorsing routine probiotic or prebiotic use for IBD.